Haohao Zhang, Mengge Guo, Zhen Kong, Yujie Ma, Laixin Hong, Mingyuan Pang, Zimai Wang, Min Yang, Juan An, Yen Leng Pak, Jibin Song
{"title":"Bismuth-based nanosystems for precise tumor theranostics: Recent progress, challenges and perspectives.","authors":"Haohao Zhang, Mengge Guo, Zhen Kong, Yujie Ma, Laixin Hong, Mingyuan Pang, Zimai Wang, Min Yang, Juan An, Yen Leng Pak, Jibin Song","doi":"10.7150/thno.140822","DOIUrl":null,"url":null,"abstract":"<p><p>Precision tumor diagnosis and treatment are constrained by inaccurate early diagnosis, therapeutic resistance, immunosuppressive tumor microenvironments, and toxic side effects of drugs, resulting in unsatisfactory efficacy of monotherapies. Multifunctional nanoplatforms capable of integrating multimodal imaging, synergistic therapy and immune regulation constitute a core research focus in precision oncology. Bi-based nanomaterials exhibit high X-ray attenuation, tunable band structures, excellent photoacoustic/catalytic performance and controllable degradability, rendering them suitable for imaging-guided precision tumor theranostics. This article systematically reviews four categories of Bi-based nanomaterials: elemental/single-phase, heterostructures, core-shell structures, and Bi-based/containing MOFs. We summarize strategies for structural modification and structure-activity relationship optimization, elaborate their advantages in multimodal imaging, as well as synergistic anti-tumor mechanisms combining phototherapy, radiotherapy, sonodynamic therapy and immunotherapy, including activation of regulated cell death, tumor microenvironment remodeling, and tumor growth inhibition and anti-metastasis effects. Furthermore, the bottlenecks hindering their clinical translation are outlined, and prospects for the development of precision nanotheranostics are proposed. This work provides theoretical references for the clinical translation of Bi-based nanomaterials for tumor theranostics.</p>","PeriodicalId":22932,"journal":{"name":"Theranostics","volume":"16 16","pages":"9484-9527"},"PeriodicalIF":14.9000,"publicationDate":"2026-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13684940/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Theranostics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.7150/thno.140822","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
Abstract
Precision tumor diagnosis and treatment are constrained by inaccurate early diagnosis, therapeutic resistance, immunosuppressive tumor microenvironments, and toxic side effects of drugs, resulting in unsatisfactory efficacy of monotherapies. Multifunctional nanoplatforms capable of integrating multimodal imaging, synergistic therapy and immune regulation constitute a core research focus in precision oncology. Bi-based nanomaterials exhibit high X-ray attenuation, tunable band structures, excellent photoacoustic/catalytic performance and controllable degradability, rendering them suitable for imaging-guided precision tumor theranostics. This article systematically reviews four categories of Bi-based nanomaterials: elemental/single-phase, heterostructures, core-shell structures, and Bi-based/containing MOFs. We summarize strategies for structural modification and structure-activity relationship optimization, elaborate their advantages in multimodal imaging, as well as synergistic anti-tumor mechanisms combining phototherapy, radiotherapy, sonodynamic therapy and immunotherapy, including activation of regulated cell death, tumor microenvironment remodeling, and tumor growth inhibition and anti-metastasis effects. Furthermore, the bottlenecks hindering their clinical translation are outlined, and prospects for the development of precision nanotheranostics are proposed. This work provides theoretical references for the clinical translation of Bi-based nanomaterials for tumor theranostics.
期刊介绍:
Theranostics serves as a pivotal platform for the exchange of clinical and scientific insights within the diagnostic and therapeutic molecular and nanomedicine community, along with allied professions engaged in integrating molecular imaging and therapy. As a multidisciplinary journal, Theranostics showcases innovative research articles spanning fields such as in vitro diagnostics and prognostics, in vivo molecular imaging, molecular therapeutics, image-guided therapy, biosensor technology, nanobiosensors, bioelectronics, system biology, translational medicine, point-of-care applications, and personalized medicine. Encouraging a broad spectrum of biomedical research with potential theranostic applications, the journal rigorously peer-reviews primary research, alongside publishing reviews, news, and commentary that aim to bridge the gap between the laboratory, clinic, and biotechnology industries.